Basit öğe kaydını göster

Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

dc.contributor.authorGumus, Mahmut
dc.contributor.authorCiltas, Aydin
dc.contributor.authorUstaalioglu, Basak Bala
dc.contributor.authorUysal, Mukremin
dc.contributor.authorEsbag, Onur
dc.contributor.authorYazilitas, Dogan
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorBilici, Ahmet
dc.contributor.authorArpaci, Erkan
dc.contributor.authorBerk, Veli
dc.contributor.authorYetisyigit, Tarkan
dc.contributor.authorOzdemir, Nuriye Yildirim
dc.contributor.authorOztop, Ilhan
dc.contributor.authorAlacacioglu, Ahmet
dc.contributor.authorAydin, Ozhan
dc.contributor.authorOzcelik, Melike
dc.contributor.authorYildirim, Emre
dc.contributor.authorKEFELİ, UMUT
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorTastekin, Didem
dc.contributor.authorAkyol, Murat
dc.contributor.authorDinc, Nur
dc.contributor.authorTanrikulu, Eda
dc.contributor.authorAydin, Dincer
dc.contributor.authorSendur, Mehmet Ali
dc.date.accessioned2021-03-04T10:48:09Z
dc.date.available2021-03-04T10:48:09Z
dc.date.issued2017
dc.identifier.citationAydin D., Sendur M. A. , KEFELİ U., Unal O. U. , Tastekin D., Akyol M., Tanrikulu E., Ciltas A., Ustaalioglu B. B. , Uysal M., et al., "Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection", CLINICAL COLORECTAL CANCER, cilt.16, sa.3, ss.220-227, 2017
dc.identifier.issn1533-0028
dc.identifier.othervv_1032021
dc.identifier.otherav_6f0cd824-57d2-4dd9-a94a-1ef101db36f5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/76659
dc.identifier.urihttps://doi.org/10.1016/j.clcc.2016.08.002
dc.description.abstractThis is a multicenter study to assess the prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma (SBA). A total of 78 patients with SBA diagnosed with completely resected SBA were involved in the study. Only status of surgical margin was determined to be an independent prognostic factor in patients with SBA who underwent curative resection. Neither disease-free survival nor overall survival was found to be significantly improved by the adjuvant chemotherapy
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleEvaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
dc.typeMakale
dc.relation.journalCLINICAL COLORECTAL CANCER
dc.contributor.departmentIstanbul Kartal Dr Lutfi Kirdar Training & Research Hospital , ,
dc.identifier.volume16
dc.identifier.issue3
dc.identifier.startpage220
dc.identifier.endpage227
dc.contributor.firstauthorID2358622


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster